SELECTBIO Conferences The RNA Summit: Research, Diagnostics & Therapeutics
The RNA Summit: Research, Diagnostics & Therapeutics
Date: November 13 - 14, 2017
Venue: Wyndham Boston Beacon Hill, Boston, Massachusetts USA

Keynote Speakers

Alexander Pertsemlidis

Alexander Pertsemlidis
Associate Professor, The University of Texas Health Science Center at San Antonio

Frank Slack

Frank Slack
Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School

Joshua Levin

Joshua Levin
Senior Scientist/Group Leader, The Broad Institute of MIT and Harvard

Louise Laurent

Louise Laurent
Associate Professor, University of California-San Diego

Anastasia Khvorova

Anastasia Khvorova
Professor, RNA Therapeutics Institute, University of Massachusetts Medical School

Joel Richter

Joel Richter
Professor of Molecular Medicine, Arthur F. Koskinas Professor of Neuroscience, University of Massachusetts Medical School


Welcome to the Select Biosciences, Inc. The RNA Summit 2017: Research, Diagnostics and Therapeutics.

This conference focuses on the studies on RNA from a research perspective, from the biomarker/diagnostic potential of various RNA species, to the therapeutic potential of RNA in various therapeutics classes.

There is also expanding interest in extracellular RNA and its potential as a circulating biomarker class for liquid biopsy development.  This is a topic addressed at this conference in the context of the diagnostic potential of RNA.

This summit is composed of research presentations, keynotes to frame the current state-of-the-art of the field as well as round-table discussions focusing on:

  • Life Science Research Activities and Opportunities in RNA
  • RNA Classes as Biomarkers (notably are microRNAs, long non-coding RNAs)
  • RNA as a Therapeutic Modality: Challenges and Current Progress

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 06 November 2017

Agenda Topics

  • Extracellular RNA in Biofluids as a Circulating Biomarker: Opportunity for Liquid Biopsy Development
  • Function of Long Non-Coding RNAs and their Biomarker Potential
  • Life Science Research in the RNA Field: Current Segments of Interest and Associated Opportunities
  • RNA-based Therapeutics
    • Clinical Pipeline
    • Delivery Technologies
    • RNAi Therapeutics: Current Status and Industry Pipeline
  • RNA-Seq for Transcriptional Characterization and Profiling
    • Front-End Sample Preparation
    • RNA-Seq Case Studies
  • Small RNAs such as microRNAs: Research and Biomarker Potential

Confirmed Speakers to date

Ruslan Afasizhev, Professor, Boston University
Aftab Ahmad, Associate Professor of Anesthesiology, Division of Molecular and Translational Biomedicine, University of Alabama at Birmingham
Maninjay Atianand, Research Fellow, University of Massachusetts Medical School
Amber Dahlin, Instructor of Medicine and Associate Epidemiologist, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School
Pavel Ivanov, Associate Member, Broad Institute of Harvard and MIT; Associate Immunologist at Brigham and Women's Hospital
Zhe Ji, Research Fellow, The Broad Institute and Harvard Medical School
Andrea Kasinski, William and Patty Miller, Assistant Professor of Biological Sciences, Purdue University
Tatsuya Kobayashi, Assistant Professor, Massachusetts General Hospital
Clotilde Lagier-Tourenne, Assistant Professor of Neurology, Massachusetts General Hospital and Harvard Medical School
Quan Lu, Associate Professor, Harvard School of Public Health
Walter Moss, Assistant Professor in the Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University
Alan Mullen, Assistant Professor, Harvard Medical School and Massachusetts General Hospital
Anders Näär, Professor, Department of Cell Biology, Harvard Medical School and Massachusetts General Hospital Cancer Center
Carl Novina, Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School; Associate Member, The Broad Institute of MIT & Harvard
Yaoyu Wang, Associate Director, Dana-Farber Cancer Institute

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Traditional Chinese
Simplified Chinese